Beta Bionics, Inc. Gross Profit
Beta Bionics, Inc. (BBNX) reported Gross Profit of $18.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-07-29
- Beta Bionics, Inc. gross profit for the quarter ending 2026-06-30 was $18.90M, a 51.18% increase year-over-year.
- Beta Bionics, Inc. gross profit for the quarter ending 2026-03-31 was $16.44M, a 83.22% increase year-over-year.
- Beta Bionics, Inc. gross profit for the quarter ending 2025-12-31 was $18.94M, a 62.07% increase year-over-year.
- Beta Bionics, Inc. gross profit for the quarter ending 2025-09-30 was $15.12M, a 69.61% increase year-over-year.
- Beta Bionics, Inc. gross profit for fiscal 2025 was $55.54M, a 54.75% increase from fiscal 2024.
- Beta Bionics, Inc. gross profit for fiscal 2024 was $35.89M, a 468.93% increase from fiscal 2023.
- Beta Bionics, Inc. gross profit for fiscal 2023 was $6.31M.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.90M 10-Q · filed 2026-07-29 | $35.34M 10-Q · filed 2026-07-29 | $54.28M derived: sum of 3 quarters · filed 2026-07-29 | $69.40M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $16.44M 10-Q · filed 2026-04-21 | $35.38M derived: sum of 2 quarters · filed 2026-04-21 | $50.50M derived: sum of 3 quarters · filed 2026-04-21 | $63.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $18.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $34.06M derived: sum of 2 quarters · filed 2026-02-24 | $46.57M derived: sum of 3 quarters · filed 2026-07-29 | $55.54M 10-K · filed 2026-02-24 |
| 2025-09-30 | $15.12M 10-Q · filed 2025-10-28 | $27.62M derived: sum of 2 quarters · filed 2026-07-29 | $36.59M 10-Q · filed 2025-10-28 | $48.28M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $12.50M 10-Q · filed 2026-07-29 | $21.47M 10-Q · filed 2026-07-29 | $33.16M derived: sum of 3 quarters · filed 2026-07-29 | $42.08M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $8.97M 10-Q · filed 2026-04-21 | $20.66M derived: sum of 2 quarters · filed 2026-04-21 | $29.57M derived: sum of 3 quarters · filed 2026-04-21 | $37.66M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.60M derived: sum of 2 quarters · filed 2026-02-24 | $28.69M derived: sum of 3 quarters · filed 2026-02-24 | $35.89M 10-K · filed 2026-02-24 |
| 2024-09-30 | $8.91M 10-Q · filed 2025-10-28 | $17.00M derived: sum of 2 quarters · filed 2025-10-28 | $24.20M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $8.08M 10-Q · filed 2025-07-29 | $15.29M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $7.20M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $6.31M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |